Mark B. Kislinger MD Inc. — Glendora, California

Mark B. Kislinger MD Inc. is a clinical research site located in Glendora, California, United States 95670.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Mark B. Kislinger MD Inc. has participated in 6 clinical trials.

Therapeutic areas: Cataract, Macular Degeneration, Glaucoma, Open-Angle.

Sponsors: Salvat, Allergan, Shire.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glendora

Browse all research sites in California · View every site in Glendora

• Citrus Valley Medical Research
• Pfizer Investigational Site
• Wilshire Oncology Medical Group
• Paradise Clinical Research Group LLC
• Foothill Cardiology Glendora
• Citrus Valley Urological Medical Group
• Senju Investigational Site
• Pain Diagnosis and Treatment
• Citrus Valley Urologic Medical Group
• Valley Gastro Consultants
• Wilshire Onc Med Grp., Inc

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mark B. Kislinger MD Inc.?

Mark B. Kislinger MD Inc. has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mark B. Kislinger MD Inc. conducted?

Mark B. Kislinger MD Inc. has 6 clinical trials on record. Their work covers Cataract, Macular Degeneration, Glaucoma, Open-Angle.

Is Mark B. Kislinger MD Inc. accredited by Crixeo Clinical Trials?

Mark B. Kislinger MD Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mark B. Kislinger MD Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.